Comments on: Ayurvedic Herbs for PCOS: A Critical Appraisal of 2024-2026 Randomized Trials

By: Nicole Hayes

Nicole Hayes — Thu, 03 Dec 2026 17:39:58 +0000

For someone trying to conceive, tracking menstrual cycles while taking Shatavari would be a practical next step.

Matthew Green — Wed, 25 Nov 2026 13:37:40 +0000

The comparison to metformin in the Kanchanara trial is interesting, but without a placebo arm it’s hard to draw firm conclusions.

Daniel Brooks — Tue, 17 Nov 2026 10:47:19 +0000

It seems reasonable to use these herbs alongside lifestyle changes rather than as a sole treatment.

Chris Morgan — Mon, 09 Nov 2026 14:42:43 +0000

Such small sample sizes increase the chance of missing real effects or overestimating them.

Rachel Adams — Sun, 01 Nov 2026 14:39:23 +0000

I noticed the Guduchi and Varuna sections mention only one trial each, which feels thin.

Karen Phillips — Sat, 24 Oct 2026 02:51:31 +0000

A longer trial of at least six months could show whether Shatavari influences ovarian volume.

Andrew Collins — Fri, 16 Oct 2026 07:36:45 +0000

The article points out that fertility outcomes like ovulation confirmation are rarely measured.

Jessica Reed — Thu, 08 Oct 2026 02:19:35 +0000

Ashwagandha’s cortisol reduction looks promising for those dealing with stress related insulin resistance.

Ashley Carter — Wed, 30 Sep 2026 06:13:02 +0000

Such open-label designs make it hard to tell if Kanchanara Guggulu really works better than usual care.

Kevin Martin — Mon, 21 Sep 2026 22:52:37 +0000

One question I have is whether the placebo in the Shatavari trial was truly inert.